O-(5-Norbornene-2,3-dicarboximido)-N,N,N′,N′-tetramethyluronium tetrafluoroborate

We are O-(5-Norbornene-2,3-dicarboximido)-N,N,N′,N′-tetramethyluronium tetrafluoroborate CAS:125700-73-4 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:O-(5-Norbornene-2,3-dicarboximido)-N,N,N′,N′-tetramethyluronium tetrafluoroborate;
CAS.NO:125700-73-4
Synonyms:2-(5-Norbornene-2,3-dicarboximido)-1,1,3,3-tetramethyluronium Tetrafluoroborate;TNTU
Molecular Formula:C14H20BF4N3O3
Molecular Weight:365.13200
 
Physical and Chemical Properties:
Melting point:216-219oC;
 
HS Code: 2925190090
UN No.: UN1759
Hazard class: 8 categories 
Packing level: Class III
 
Specification:
Appearance:Off-white to white crystalline powder
Purity(HPLC):≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:As a condensation reagent
 

O-(5-Norbornene-2,3-dicarboximido)-N,N,N′,N′-tetramethyluronium tetrafluoroborate


Related News: Because API companies usually adopt a different synthetic route from the original research company, compared with the drug itself, the impurities contained in the generic drug API have not been verified by the original drug for many years of use and require more careful testing and control.5-Octanoylsalicylic acid CAS:78418-01-6 Trial results demonstrated that Oligomannate statistically improved cognitive function in mild-to-moderate AD patients as early as week 4 and the benefit was sustained at each follow-up assessment visit,” Shanghai Green Valley Pharmaceuticals, which developed the drug along with two academic institutions in China, said in a statement.2,7-Dibromo-9,9-difluoro-9H-fluorene CAS:1229603-71-7 API (Active Pharmaceutical Ingredient) means the active ingredient which is contained in medicine. Ácido oleico CAS:112-80-1 Under the terms of the agreement, ICIG will purchase substantially all of the pharmaceutical intermediates business, excluding the drug delivery technologies portion of the business.Only when the drug substance is processed into a pharmaceutical preparation can it become a drug for clinical application.

Related Products
Product Name
Chain Extender HQEE View Details
Adenosine 5′-triphosphate Disodium Salt ATP Cas:987-65-5 View Details
Octabenzone View Details
Dimethyl Sulfoxide (DMSO) Cas:67-68-5 manufacturer DL-Aspartic Acid manufacturer glyceryl tribenzOate Cas:614-33-5 manufacturer Cytidine 5′-diphosphate Disodium Salt (CDP-Na2) Cas:54394-90-0 manufacturer COCONUT OIL Cas:8001-31-8 manufacturer